Aristotle Capital Boston »

Cerence shares owned by Aristotle Capital Boston

Quarter-by-quarter ownership of Cerence (CRNC) shares owned by Aristotle Capital Boston from 13F filings

Historical chart of Aristotle Capital Boston investment in Cerence

Tip: Access up to 7 years of quarterly data

All positions including Cerence held by Aristotle Capital Boston consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerence by Aristotle Capital Boston

Quarter filed Position value Share count Share price at filing
2023-09-30 $9.5M 467k 20.37
2023-06-30 $2.7M 93k 29.23

More positions owned by Aristotle Capital Boston

Huron Consulting (HURN)
M/a (MTSI)
Acadia Healthcare (ACHC)
Belden (BDC)
Merit Medical Systems (MMSI)
Aercap Holdings Nv SHS (AER)
Advanced Energy Industries (AEIS)
Chemed Corp Com Stk (CHE)
Itron (ITRI)
On Assignment (ASGN)
Albany Intl Corp Cl A (AIN)
Healthequity (HQY)
Oceaneering International (OII)
KBR (KBR)
Dycom Industries (DY)

View all positions for Aristotle Capital Boston

Top funds holding Cerence

Vanguard Group
Van Berkom & Associates
Dimensional Fund Advisors
Luke P. La Valle, Jr.
Gail Mannix
Charles Schwab Investment Management
Bank of New York Mellon
Millennium Management
Mirae Asset Global Investments
Meros Investment Management
Goldman Sachs Group
Arrowpoint Asset Management
Norges Bank Investment Management
Citadel Advisors
Principal Financial Group

View all funds holding Cerence